3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
53
Colonic Neoplasms
11
Neoplasms
10
Rectal Neoplasms
9
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Lung Neoplasms
4
Gastrointestinal Neoplasms
4
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Unresectable Metastatic Colorectal Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Ras-mutated Metastatic Colorectal Cancer
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neuroendocrine Tumors
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Sirolimus
1
Panitumumab
1
Irinotecan
1
IFL protocol
1
Gels
1
Doxycycline
1
Dapsone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Exanthema
×
IFL protocol
×
Clear all
NCT00332163
2016-02-23
STEPP
Amgen
Phase 2
Completed
95 enrolled
23 charts